PF-Atlas › Clinical Trials › NCT02562716
S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Fluorouracil · Phase 2
Registry ID
NCT02562716
Phase
Phase 2
Status
Completed
Drug / intervention
Fluorouracil
Sponsor
SWOG Cancer Research Network
Start
2016-01-06
About this trial
Fluorouracil is evaluated in NCT02562716, a Phase 2 idiopathic pulmonary fibrosis study sponsored by SWOG Cancer Research Network. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT02562716 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.